Home LiteratureArticle Details
PMID: 25209180 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Significance of -1082A/G polymorphism of IL10 gene for progression of colorectal cancer and IL-10 expression.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine ·Vol. 35 ·No. 12 ·2014-12-00 ·Pages 12655-64

Miteva LD, Stanilov NS, Deliysky TS, Stanilova SA

Abstract

The role of functional polymorphism within IL10 (rs1800896) in colorectal cancer (CRC) still remains elusive. The aim of present study was to investigate the significance of -1082A/G polymorphism in IL10 on CRC risk, progression, and overall survival in a cohort of Bulgarian patients. Also, a functional role of this polymorphism on systemic and local level of IL10 mRNA quantity and serum IL-10 level was explored. A group of 119 patients with sporadic CRC and 154 age-sex-matched controls were genotyped by allele-specific PCR. The quantification of mRNA and serum IL-10 levels was performed by real-time PCR and ELISA assays, respectively. The genotype and allelic frequency among cases and controls was similar. However, we observed significant elevation of G-allele and GG-genotype frequencies among advanced CRC. G-allele was overrepresented in advanced CRC patients (49 %) compared to early CRC (35 %) with OR = 1.77; 95%CI 1.018 ÷ 3.083; P = 0.031. A significant upregulated expression of IL10 mRNA was observed among AG/GG-genotypes in tumor tissue compared to homozygous AA-genotype (RQ value 68.3 vs. 6.68; P = 0.0062). Also, GG-genotype of -1082A/G polymorphism in IL10 was positively associated with higher serum IL-10 among early CRC patients and controls, in contrast to advanced cases. Although, investigated polymorphism in IL10 has no significant impact of overall survival among Bulgarian CRC patients, we found a significant relationship of high pre-operative serum level of IL-10 with poor survival of CRC (P = 0.023). Our findings indicate a significant impact of -1082A/G polymorphism of IL10 on CRC progression, rather than genetic predisposition and prognosis of CRC.

MeSH Terms
Aged Aged, 80 and over Alleles Case-Control Studies Colorectal Neoplasms/blood,genetics,mortality,pathology Disease Progression Gene Expression Gene Frequency Genotype Humans Interleukin-10/blood,genetics Middle Aged Neoplasm Grading Neoplasm Metastasis Neoplasm Staging Odds Ratio Polymorphism, Single Nucleotide Prognosis
Chemicals
Interleukin-10
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Miteva Lyuba D
Department of Molecular Biology, Immunology and Medical Genetics, Medical Faculty, Trakia University, Armeiska 11 St., 6000, Stara Zagora, Bulgaria.
Stanilov Noyko S
Deliysky Tashko S
Stanilova Spaska A
References (26)
26 references, click to expand
  1. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.
    Carcinogenesis. 2008 Aug;29(8):1572-80 PMID: 18628251
  2. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies.
    Cancer. 1999 Nov 15;86(10):1936-43 PMID: 10570416
  3. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.
    Crit Rev Immunol. 2012;32(1):23-63 PMID: 22428854
  4. Immune microenvironments in solid tumors: new targets for therapy.
    Genes Dev. 2011 Dec 15;25(24):2559-72 PMID: 22190457
  5. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.
    Anticancer Res. 2009 Dec;29(12):5005-12 PMID: 20044609
  6. Regulatory lymphocytes and intestinal inflammation.
    Annu Rev Immunol. 2009;27:313-38 PMID: 19302043
  7. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
    Methods. 2001 Dec;25(4):402-8 PMID: 11846609
  8. Cytokine promoter polymorphisms and risk of colorectal cancer.
    Clin Lab. 2013;59(7-8):773-9 PMID: 24133905
  9. Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma.
    Ann N Y Acad Sci. 2006 Nov;1089:98-103 PMID: 17261758
  10. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility.
    Intensive Care Med. 2006 Feb;32(2):260-266 PMID: 16435103
  11. The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival.
    Br J Cancer. 2006 May 22;94(10):1412-9 PMID: 16641913
  12. Meta-analysis of epidemiological studies of association of two polymorphisms in the interleukin-10 gene promoter and colorectal cancer risk.
    Genet Mol Res. 2012 Sep 25;11(3):3389-97 PMID: 23079832
  13. Interleukin-10 and the immune response against cancer: a counterpoint.
    J Leukoc Biol. 2005 Nov;78(5):1043-51 PMID: 16204623
  14. Sp1 binds to the G allele of the-1087 polymorphism in the IL-10 promoter and promotes IL-10 mRNA transcription and protein production.
    Genes Immun. 2010 Mar;11(2):181-7 PMID: 20072143
  15. Interleukin-10: new perspectives on an old cytokine.
    Immunol Rev. 2008 Dec;226:205-18 PMID: 19161426
  16. Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer.
    Clin Colorectal Cancer. 2008 Sep;7(5):331-7 PMID: 18794066
  17. An investigation of polymorphism in the interleukin-10 gene promoter.
    Eur J Immunogenet. 1997 Feb;24(1):1-8 PMID: 9043871
  18. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
    Carcinogenesis. 2008 Jun;29(6):1202-6 PMID: 18448485
  19. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer.
    Cancer Causes Control. 2009 Nov;20(9):1739-51 PMID: 19760027
  20. Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice.
    Comp Med. 2008 Dec;58(6):534-41 PMID: 19149410
  21. What are regulatory T cells (Treg) regulating in cancer and why?
    Semin Cancer Biol. 2012 Aug;22(4):327-34 PMID: 22465232
  22. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence.
    Immunogenetics. 1997;46(2):120-8 PMID: 9162098
  23. Interleukin-10 and the interleukin-10 receptor.
    Annu Rev Immunol. 2001;19:683-765 PMID: 11244051
  24. Cytokines and Immune Response in the Tumor Microenvironment.
    J Immunother (1991). 2001 Sep-Oct;24(5):392-407 PMID: 11685082
  25. The combined effect of interleukin (IL)-10 and IL-12 polymorphisms on induced cytokine production.
    Hum Immunol. 2008 Sep;69(9):562-6 PMID: 18703108
  26. Inflammation and colon cancer.
    Gastroenterology. 2010 Jun;138(6):2101-2114.e5 PMID: 20420949
Article Info
Journal
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Abbr.
Tumour Biol
ISSN
1423-0380
Published
2014-12-00
Epub
2014-00-11
Pages
12655-64
Language
English
Region
Netherlands
NLM ID
8409922
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com